Author:
Oriana Ciani,Manyara Anthony,Davies Philippa,Stewart Derek,Weir Christopher,Young Amber,Blazeby Jane,Butcher Nancy,Bujkiewicz Sylwia,Chan An-Wen,Dawoud Dalia,Offringa Martin,Ouwens Mario,Hróbjartsson Asbjørn,Amstutz Alain,Bertolaccini Luca,Bruno Vito D.,Devane Declan,Faria Christina,Gilbert Peter B.,Harris Ray,Lassere Marissa,Marinelli Lucio,Markham Sarah,Powers John,Rezaei Yousef,Richert Laura,Schwendicke Falk,Tereshchenko Larisa,Thoma Achilles,Turan Alparslan,Worrall Andrew,Christiansen Robin,Collins Gary,Ross Joseph,Taylor Rod S.
Reference48 articles.
1. Aducanumab for Alzheimer's disease?;S Walsh;BMJ,2021
2. Lecanemab for Alzheimer's disease;S Walsh;BMJ,2022
3. Novel Alzheimer disease treatments and reconsideration of us pharmaceutical reimbursement policy;M B Rosenthal;JAMA,2023
4. Reply to Commentary by Cummings (2022): Surrogate endpoints extend beyond biomarkers;A M Manyara;Alzheimers Dement,2022